Thrombin induces neoangiogenesis in the chick chorioallantoic membrane

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 10, 2003, Pages 2097-2102

  Caunt, M ^a   Huang, Y Q ^a   Brooks, P C ^a   Karpatkin, S ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Angiopoietin 2; Chorioallantoic membrane; PAR 1; Thrombin; VEGF

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ENZYME INHIBITOR; MESSENGER RNA; PEPTIDE; PROTEINASE ACTIVATED RECEPTOR 1; RECOMBINANT PROTEIN; THROMBIN; THROMBOSPONDIN 1; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANIMAL; ARTICLE; CHEMISTRY; CHICK EMBRYO; CHORION; DOSE RESPONSE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PHENOTYPE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TIME; UPREGULATION;

ANGIOPOIETIN-2; ANIMALS; CHICK EMBRYO; CHORION; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDES; PHENOTYPE; RECEPTOR, PAR-1; RECEPTOR, TIE-2; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; THROMBIN; THROMBOSPONDIN 1; TIME FACTORS; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 3042697202     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00426.x     Document Type: Article

References (38)

1. Nierodzik ML, Kajumo F, Karpatkin S. Effect of thrombin treatment of tumor cells on adhesion of tumor cells to platelets in vitro and metastasis in vivo. Cancer Res 1992; 52: 3267-72.
2. Klepfish A, Greco MA, Karpatkin S. Thrombin stimulates tumor cell binding to endothelial cells and subendothelial matrix. Int J Cancer 1993; 53: 978-82.
3. Zain J, Huang Y-Q, Feng X-S, Nierodzik ML, Li J-J, Karpatkin S. Concentration-dependent dual effect of thrombin on impaired growth/apoptosis or mitogenesis in tumor cells. Blood 2000; 95: 3133-8.
4. Nierodzik ML, Chen K, Takeshita K, Li J-J, Huang Y-Q, Feng X-S, D'Andrea MR, Andrade-Gordon P, Karpatkin S. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis. Blood 1998; 92: 3694-700.
5. Huang Y-Q, Li J-J, Hu L, Lee M, Karpatkin S. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes. Thromb Haemost 2001; 86: 1094-8.
6. Huang Y-Q, Li J-J, Hu L, Lee M, Karpatkin S. Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells. Blood 2002; 99: 1646-50.
7. Li J-J, Huang Y-Q, Basch R, Karpatkin S. Thrombin induces the release of angiopoietin-1 from platelets. Thromb Haemost 2001; 85: 204-6.
8. Tsopanoglou NE, Maragoudakis ME. On the mechanism of thrombin-induced angiogenesis. Potentiation of vascular endothelial growth factor activity on endothelial cells by up-regulation of its receptors. J Biol Chem 1999; 274: 23969-76.
9. Wang JIE, Morita I, Onodera M, Murota S-I. Induction of KDR expression in bovine arterial endothelial cells by thrombin: involvement of nitric oxide. J Cell Physiol 2002; 190: 238-50.
10. Pepper MS, Ferrara N, Orci L, Montesano R. Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992; 189: 824-31.
11. Eriksson U, Alitalo K. Structure, expression and receptor-binding properties of novel vascular endothelial growth factors. Curr Top Microbiol Immunol 1999; 237: 41-57.
12. Veikkola T, Karkainen MJ, Claesson-Welsh L, Alitalo K. Regulation of angiogenesis via vascular endothelial growth factor receptors. Cancer Res 2000; 60: 203-12.
13. Soker S, Takashima S, Miao HQ, Neufeld G, Klagsbrun M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-speciic receptor for vascular endothelial growth factor. Cell 1998; 92: 735-45.
14. Davis S, Aldrich TH, Jones PF, Acheson A, Compton DL, Jain V, Ryan TE, Bruno J, Radziejewski C, Maisonpierre PC, Yancopoulos GD. Isolation of angiopoietin-1, a ligand for the TIE-2 receptor, by secretion-trap expression cloning. Cell 1996; 87: 1161-9.
15. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, Yancopoulos GD. Requisite role of angiopoietin-1, a ligand for the TIE-2 receptor, during embryonic angiogenesis. Cell 1996; 87: 1171-80.
16. Thurston G, Suri C, Smith K, McClain J, Sato N, Yancopoulos GD, McDonald DM. Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 1999; 286: 2511-4.
17. Maisonpierre PC, Suri C, Jones PF, Bartunkova B, Wiegand SJ, Radziejewski C, Compton D, McClain J, Aldrich TH, Papadopoulos N, Daly TJ, Davis S, Sato TN, Yancopoulos GD. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science 1997; 277: 55-60.
18. Koblizek TI, Weiss C, Yancopoulos GD, Deutsch U, Risau W. Angio-poietin-1 induces sprouting angiogenesis in vitro. Current Biol 1998; 8: 529-32.
19. Oh H, Takagi H, Suzuma K, Otani A, Matsumura M, Honda Y. Hypoxia and vascular endothelial growth factor selectively up-regulate angio-poietin-2 in bovine microvascular endothelial cells. J Biol Chem 1999; 274: 15732-9.
20. Brooks PC, Clark RA, Cheresh DA. Requirement of vascular integrin aVb3 for angiogenesis. Science 1994; 264: 569-71.
21. Brooks PC, Montgomery AM, Cheresh DA. Use of the 10-day-old chick embryo. Model for studying angiogenesis. Meth Mol Biol 1999; 129: 257-69.
22. Huang Y-Q, Li J-J, Karpatkin S. Identiication of a family of alternatively spliced mRNA species of angiopoietin-1. Blood 2000; 95: 1993-9.
23. Haralabopoulos GC, Grant DS, Kleinman HK, Maragoudakis ME. Thrombin promotes endothelial cell alignment in matrigel in vitro and angiogenesis in vivo. Am J Physiol 1997; 273: 239-45.
24. Maragoudakis ME, Kraniti N, Giannopoulou E, Alexopoulos K, Mat-soukas J. Modulation of angiogenesis and progelatinase a by thrombin receptor mimetics and antagonists. Endothelium 2001; 8: 195-205.
25. Carter AN, Huang R, Sorisky A, Downes CP, Rittenhouse SE. Phos-phatidylinositol 3,4,5-trisphosphate is formed from phosphatidylinosi-tol 4,5-bisphosphate in thrombin-stimulated platelets. Biochem J 1994; 301: 415-20.
26. Gutkind JS, Lacal PM, Robbins KC. Thrombin-dependent association of phosphatidylinositol-3 kinase with p60c-src and p59fyn in human platelets. Mol Cell Biol 1990; 10: 3806-9.
27. Ha KS, Exton JH. Differential translocation of protein kinase C isozymes by thrombin and platelet-derived growth factor. A possible function for phosphatidylcholine-derived diacylglycerol. J Biol Chem 1993; 268: 10534-9.
28. Leach KL, Ruff VA, Jarpe MB, Adams LD, Fabbro D, Raben DM. Alpha-thrombin stimulates nuclear diglyceride levels and differential nuclear localization of protein kinase C isozymes in IIC9 cells. J Biol Chem 1992; 267: 21816-22.
29. Mazure NM, Chen EY, Laderoute KR, Giaccia AJ. Induction of vascular endothelial growth factor by hypoxia is modulated by a phosphatidy-linositol 3-kinase/Akt signaling pathway in Ha-ras-transformed cells through a hypoxia inducible factor-1 transcriptional element. Blood 1997; 90: 3322-31.
30. Papkoff J, Chen RH, Blenis J, Forsman J. p42 mitogen-activated protein kinase and p90ribosomal S6 kinase are selectively phosphorylated and activated during thrombin-induced platelet activation and aggregation. Mol Cell Biol 1994; 14: 463-72.
31. Trousseau A. Phelgmasia alba dolens. Clinique Medicale de Hotel-Dieu de Paris. London: New Sydenham Society, 1865; 3: 94.
32. Merskey C, Johnson AJ, Harris JU, Want MT, Swain S. Isolation of ibrinogen-ibrin related antigen from human plasma by immune-afinity chromatography: its characterization in normal subjects and in deibrinating patients with abruptio placentae and disseminated cancer. Br J Haematol 1980; 44: 655-70.
33. Peuscher FW, Cleton FJ, Armstrong L, Stoepman van Dalen EA, van Aken WG. Significance of plasma fibrinopeptide A (FPA) in patients with malignancy. J Lab Clin Med 1980; 96: 5-14.
34. Rickles FR, Edwards RC, Barb C, Cronlund M. Abnormalities of blood coagulation in patients with cancer: ibrinopeptide A generation and tumor growth. Cancer 1983; 51: 301-7.
35. Yoda Y, Abe T. Fibrinopeptide A (FPA) level and ibrinogen kinetics in patients with malignant disease. Thromb Haemost 1981; 46: 706-9.
36. Klepish A, Greco MA, Karpatkin S. Thrombin stimulates melanoma tumor-cell binding to endothelial cells and subendothelial matrix. Int J Cancer 1993; 53: 978-82.
37. Nierodzik ML, Bain MR, Liu L-X, Shivji M, Takeshita K, Karpatkin S. Presence of the seven transmembrane thrombin receptor on human tumor cells: effect of activation on tumor adhesion to platelets and tumor tyrosine phosphorylation. Br J Haematol 1996; 92: 452-7.
38. Nierodzik ML, Plotkin A, Kajumo F, Karpatkin S. Thrombin stimulates tumor-platelet adhesion in vitro and metastasis in vivo. J Clin Invest 1991; 87: 229-36.